![](https://investorshub.advfn.com/uicon/374489.png?cb=1595535472)
Saturday, February 02, 2013 8:59:33 AM
Amarantus BioSciences Inc.closed a $10 million equity funding facility with Centurion Private Equity LLC.
The Sunnyvale-based biotechnology company (OTCBB:AMBS) said it will be able to draw down on the facility over the next 36 months in tranches of up $750,000.
Amarantus BioSciences is developing biologics to treat Parkinson's and other human diseases.
AMBS can still draw on this...
http://www.bizjournals.com/sanjose/news/2011/10/13/amarantus-biosciences-secures-10m.html
LEGIT COMPANIES HAVE MONEY AFFORDED TO THEM WHILE THEY COMPLETE THEIR GROUND BREAKING RESEARCH>>>
MANF = POTENTIAL BLOCK BUSTER DRUG
Words of Dr. Joseph Rubinfeld - Co-Founder of AMGEN
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM